NSUN7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.388400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.702000E-01
Normal-vs-Stage2
5.288600E-01
Normal-vs-Stage3
4.671800E-01
Normal-vs-Stage4
3.125600E-01
Stage1-vs-Stage2
5.680200E-01
Stage1-vs-Stage3
5.385900E-02
Stage1-vs-Stage4
7.514000E-01
Stage2-vs-Stage3
9.910100E-02
Stage2-vs-Stage4
4.161800E-01
Stage3-vs-Stage4
4.347500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.488200E-01
Normal-vs-AfricanAmerican
7.833600E-01
Normal-vs-Asian
2.625600E-01
Caucasian-vs-AfricanAmerican
7.073600E-01
Caucasian-vs-Asian
1.158990E-01
AfricanAmerican-vs-Asian
2.441400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.797600E-01
Normal-vs-Female
6.244600E-01
Male-vs-Female
3.703400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.872400E-01
Normal-vs-Age(41-60Yrs)
4.378600E-01
Normal-vs-Age(61-80Yrs)
5.758600E-01
Normal-vs-Age(81-100Yrs)
9.320200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.954600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.699000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.788800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.205000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.853390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.600800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.240800E-01
Normal-vs-Daily Drinker
5.001400E-01
Normal-vs-Weekly Drinker
7.505600E-01
Normal-vs-Occasional Drinker
2.633000E-01
Normal-vs-Social Drinker
7.924400E-01
Non Drinker-vs-Daily Drinker
8.309800E-01
Non Drinker-vs-Weekly Drinker
4.649400E-01
Non Drinker-vs-Occasional Drinker
3.262000E-01
Non Drinker-vs-Social Drinker
1.930050E-01
Daily Drinker-vs-Weekly Drinker
4.675800E-01
Daily Drinker-vs-Occasional Drinker
5.505400E-01
Daily Drinker-vs-Social Drinker
1.889780E-01
Weekly Drinker-vs-Occasional Drinker
1.763180E-01
Weekly Drinker-vs-Social Drinker
7.352200E-01
Occasional Drinker-vs-Social Drinker
3.549700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.095620E-01
Normal-vs-Grade 2
2.795500E-02
Normal-vs-Grade 3
1.129870E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.632400E-01
Grade 1-vs-Grade 3
9.532200E-01
Grade 1-vs-Grade 4
1.095620E-01
Grade 2-vs-Grade 3
6.977200E-01
Grade 2-vs-Grade 4
2.795500E-02
Grade 3-vs-Grade 4
1.129870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.209600E-01
Normal-vs-NonDiabetic
4.595600E-01
Diabetic-vs-NonDiabetic
1.582840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.135800E-01
Normal-vs-NoPancreatitis
5.927400E-01
Pancreatitis-vs-NoPancreatitis
1.119400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.389800E-01
Normal-vs-N1
5.511800E-01
N0-vs-N1
8.765800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.704180E-01
Normal-vs-TP53-NonMutant
4.150200E-01
TP53-Mutant-vs-TP53-NonMutant
3.019600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
